eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees

Journal integrated with

integrated with publons
3/2020
vol. 52
 
Share:
Send email
Share:
abstract:
Letter to the Editor

Implementation of veno-venous extracorporeal membrane oxygenation in a COVID-19 convalescent

Ryszard Gawda
1
,
Maciej Marszalski
1
,
Maciej Molsa
1
,
Maciej Piwoda
1
,
Marek Pietka
1
,
Maciej Gawor
1
,
Wojciech Mielnicki
2
,
Agnieszka Dyla
2
,
Tomasz Czarnik
3

  1. Department of Anesthesiology, Intensive Care and Regional ECMO Center, University Hospital, Opole, Poland
  2. Anaesthesiology and Intensive Care Unit, District Hospital in Olawa, Poland
  3. Department of Anesthesiology, Intensive Care and Regional ECMO Center, Institute of Medical Sciences, University of Opole, Opole, Poland
Anaesthesiol Intensive Ther 2020; 52, 3: 253–255
DOI: https://doi.org/10.5114/ait.2020.97956
Online publish date: 2020/08/06
View full text Get citation
 
PlumX metrics:
Dear Editor,
We would like to present a case of successful implementation of veno-venous extracorporeal membrane oxygenation (ECMO) in a COVID-19 convalescent. Many experts suggest that during a pandemic ECMO should be applied in strictly defined cases for COVID-19 patients, mainly because of the resource-consuming nature of extracorporeal therapy [1, 2]. Current guidelines state that ECMO is contraindicated after seven days of mechanical ventilation, including in critically ill COVID-19 patients [3]. Extracorporeal treatment in our COVID-19 convalescent was launched at the late stage of severe acute respiratory distress syndrome (ARDS), which was also affected by the onset of septic shock. We believe that this is the first case of ECMO therapy in a COVID-19 convalescent to be described in the literature. Written informed consent from the patient was obtained to present this case.
A 28-year old, previously healthy man was referred to the ECMO centre by the Intensive Care Unit (ICU) of the regional hospital. The patient had been mechanically ventilated due to acute respiratory failure for 12 days.
Before admission to the ICU, he had been treated in an isolation ward because of symptoms of dyspnoea, coughing, and fever, which slowly escalated seven days before hospitalization. At the isolation ward, a qualitative antibody IgG/IgM SARS-CoV-2 rapid test was positive, and a viral test from a nasopharyngeal swab (SARS-CoV-2 RT-PCR test) yielded ambiguous results (only nucleocapsid of the virus was detected). The next two viral tests from a nasopharyngeal swab performed were negative.
Because of respiratory deterioration the patient was then transferred to the ICU. Laboratory tests in the ICU on the admission day showed procalcitonin (PCT) of 0.2 mg L-1, C-reactive protein (CRP) of 122 mg L-1, and white blood cells (WBCs) 8.55 G L-1. The SARS-CoV-2 RT-PCR test from bronchoalveolar lavage performed in the ICU was negative, but the quantitative antibody SARS-CoV-2 test revealed an IgG titre of 10.18 (positive value > 1.1) and IgM titre of 2.835 (positive value > 1.1). The epidemiological history of the patient was eminently positive – the rest of his family from the same household had been positively diagnosed with COVID-19. For the above reasons, the patient in the ICU was treated as a COVID-19 convalescent.
In the ICU, the patient was ventilated using a tidal volume below 6 mL kg-1 of predicted body weight, with a high ratio of...


View full text...
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.